Oncotaxel

Product TA
Antineoplastic
Active Ingredient
Docetaxel
Route Of Administration
IV
Product type
Specialty




Product Details

Specialty
Oncology
Strength
20 mg
Product Form
Vial
Registration Number
DKI1629200649A1



Product Details

Specialty
Oncology
Strength
80 mg
Product Form
Vial
Registration Number
DKI1829200849A1

Additional products

Plaxat

Product TA
Antineoplastic
Active Ingredient
Oxaliplatin
Route Of Administration
IV
Product type
Specialty
View Product

Lezra

Product TA
Antineoplastic
Active Ingredient
Letrozole
Route Of Administration
Oral
Product type
Specialty
View Product

Tinibat

Product TA
Antineoplastic
Active Ingredient
Imatinib
Route Of Administration
Oral
Product type
Specialty
View Product

Gemtavis

Product TA
Antineoplastic
Active Ingredient
Gemcitabine
Route Of Administration
IV
Product type
Specialty
View Product

Page Last Updated: